Cardiac Safety with High Cumulative Dose of Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer Previously Treated with Conventional Anthracyclines

Cumulative Dose ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Cardiac Safety ◽

High Cumulative Dose ◽

A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0542-4 ◽

2007 ◽

Vol 61 (5) ◽

pp. 847-853 ◽

Cited By ~ 5

Author(s):

Ruey-Long Hong ◽

Ching-Hung Lin ◽

Tsu-Yi Chao ◽

Woei-You Kao ◽

Cheng-Hsu Wang ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Salvage Chemotherapy ◽

Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study

Annals of Oncology ◽

10.1093/annonc/mdr024 ◽

2011 ◽

Vol 22 (12) ◽

pp. 2591-2596 ◽

Cited By ~ 20

Author(s):

M. Martín ◽

P. Sánchez-Rovira ◽

M. Muñoz ◽

J.M. Baena-Cañada ◽

J.R. Mel ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Cardiac Safety ◽

Her2 Positive

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

European Journal of Cancer ◽

10.1016/j.ejca.2011.08.004 ◽

2011 ◽

Vol 47 (16) ◽

pp. 2396-2402 ◽

Cited By ~ 8

Author(s):

E. Curtit ◽

P. Nouyrigat ◽

N. Dohollou ◽

E. Levy ◽

A. Lortholary ◽

...

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2007.n.028 ◽

2007 ◽

Vol 7 (9) ◽

pp. 690-696 ◽

Cited By ~ 21

Author(s):

Eleni Andreopoulou ◽

Darci Gaiotti ◽

Eugene Kim ◽

Matthew Volm ◽

Ruth Oratz ◽

...

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Cardiac Safety ◽

Heavily Pretreated ◽

Pretreated Patients

Pegylated liposomal doxorubicin (PLD) plus cyclophosphamide as 1st-line therapy for metastatic breast cancer in patients previously treated with anthracyclines

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.745 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 745-745 ◽

Cited By ~ 1

Author(s):

M. E. Trudeau ◽

L. Provencher ◽

L. Panasci ◽

L. Yelle ◽

J. Latreille ◽

...

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Line Therapy ◽

The Clinical Benefit of Pegylated Liposomal Doxorubicin in Patients With Metastatic Breast Cancer Previously Treated With Conventional Anthracyclines: A Multicentre Phase II Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(07)80277-3 ◽

2007 ◽

Vol 18 (2) ◽

pp. 205

Author(s):

A.C. Wolff

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicentre Phase ◽

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Oncology ◽

10.1159/000093005 ◽

2006 ◽

Vol 70 (2) ◽

pp. 141-146 ◽

Cited By ~ 37

Author(s):

Salah-Eddin Al-Batran ◽

Hans-Gerd Meerpohl ◽

Gunter von Minckwitz ◽

Akin Atmaca ◽

Ulrich Kleeberg ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicenter Phase ◽

Previously Treated Patients ◽

Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines

Journal of Chemotherapy ◽

10.1179/joc.2011.23.3.158 ◽

2011 ◽

Vol 23 (3) ◽

pp. 158-162 ◽

Cited By ~ 3

Author(s):

L. Livi ◽

I. Meattini ◽

V. Scotti ◽

C. De Luca Cardillo ◽

A. Galardi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Oral Vinorelbine ◽

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603158 ◽

2006 ◽

Vol 94 (11) ◽

pp. 1615-1620 ◽

Cited By ~ 49

Author(s):

S-E Al-Batran ◽

J Bischoff ◽

G von Minckwitz ◽

A Atmaca ◽

U Kleeberg ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Multicentre Phase ◽

467 PUBLICATION Pegylated liposomal doxorubicin (PLD) plus cyclophosphamide as 1st-line therapy for metastatic breast cancer in patients previously treated with anthracyclines

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80764-5 ◽

2005 ◽

Vol 3 (2) ◽

pp. 130-131

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Line Therapy ◽